Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07042243 · ClinicalTrials.gov registry record · NA

The Florida ASCENT Study

A NA study of Breast Cancer and Prostate Cancer, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07042243: Recruiting NA study of Breast Cancer and Prostate Cancer, sponsored by University of Florida.

NCT07042243 is a NA study of Breast Cancer and Prostate Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07042243, a NA study of Breast Cancer and Prostate Cancer, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer. The main hypotheses it aims to test are: * At the patient level, the intervention will result in higher levels of food security, self- efficacy for dietary behaviors, and higher diet quality than standard care. * At the provider level, the intervention will be feasible, acceptable, appropriate, and able to enhance individualized care for patient wellness. Researchers will compare cancer patients receiving the MyCarePulse and ASCENT patient navigator intervention to those receiving standard care, to see if the intervention improves food security, self-efficacy, and diet quality. Phase 1 Patient Participants will: * Complete the ASCENT Questionnaire, which is comprised of the following: * U.S. Food Security Survey Module (U.S. FSSM) * Patient-Reported Outcomes Measurement Information System (PROMIS-29) * Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool * Be assessed using the Veggie Meter instrument * Participate in two semi-structured interviews Provider Participants will: •Participate in one semi-structured interview Phase 2 Patient Participants will: * Participate in ASCENT patient navigator screenings and consultations * Complete the ASCENT Questionnaire, which comprises the U.S. FSSM, PROMIS-29, and ASA24®

Primary Outcome

Self-reported by patient using the US Food Security Module (US FSSM). The US FSSM consists of 18 questions for homes with children under the age of 18 years and 10 items for households without children, e.g., a query regarding the use of emergency foods from food banks, soup kitchens, or other organizations by household members within the past year. The overall food security status (full, marginal, low and very low) will be determined by the number of affirmative responses to those questions.

Interventions

  • BEHAVIORAL MyCarePulse and ASCENT PN

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-12-05
Est. Completion 2027-08
Phase NA
University of Florida

1,106 total trials

What NCT07042243 shows while recruiting

NCT07042243 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).

The record links to 10 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MyCarePulse and ASCENT PN is the first listed.

NCT07042243 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07042243 about?

NCT07042243 is a clinical study titled "The Florida ASCENT Study". The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer. The main hypotheses it aims to test are: * At the patient level, the intervention will result in higher levels of food security, se...

What is the current status of trial NCT07042243?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-05. Estimated completion is 2027-08.

What conditions does trial NCT07042243 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Cancer, Lung Cancer, Colorectal Cancer.

What interventions are being tested in trial NCT07042243?

The interventions under investigation include: MyCarePulse and ASCENT PN (BEHAVIORAL).

Who is sponsoring clinical trial NCT07042243?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07042243 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07042243's enrollment target sits among peer trials

100 565th of 1224 higher than 630 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07042243, the US trial registry maintained by the National Library of Medicine. NCT07042243 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.